Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Mutations of the interfacial residues in DET1 to glycine or alanine, including R488A/H485G, R488A/H485G/R306G/S312G or R488A/H485G/E380A/T382A reduced the interaction between DET1 and COP1
For example, if you always want to draw 50 units (0.50 mL) per dose for consistency: At 2.5 mg dose: Reconstitute for 5 mg/mL (2.5 divided by 5 = 0.50 mL) At 5 mg dose: Reconstitute for 10 mg/mL (5 divided by 10 = 0.50 mL) At 7.5 mg dose: Reconstitute for 15 mg/mL (7.5 divided by 15 = 0.50 mL) This "consistent draw" approach reduces the chance of dosing errors when transitioning between dose levels because you always draw the same volume
Supporting this, promoter analysis of the human CYP51A1 gene in JEG-3 cellsengineered to overexpress sterol regulatory element-binding protein 1a (SREBF1a)confirmed the presence of multiple regulatory motifs, including a GC box, a cAMP response element (CRE), and a sterol regulatory element (SRE), indicating that human CYP51A1 transcription is co-regulated by both cAMP- and sterol-dependent pathways [37]
Important: The following is general reconstitution and handling reference for laboratory research only
2022 NEJM) showed 20.9% on tirzepatide 15 mg at 72 weeks
Rare but serious effects include pancreatitis risk
US$ 25.19
US$ 26.11
US$ 22.16
US$ 23.75
